These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 34032997)
21. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays. Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N; Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976 [TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala. Davila-Siliezar P; Wer A; Barnoya J Ann Med; 2021 Dec; 53(1):1956-1959. PubMed ID: 34727801 [TBL] [Abstract][Full Text] [Related]
23. Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021. Stringhini S; Zaballa ME; Pullen N; Perez-Saez J; de Mestral C; Loizeau AJ; Lamour J; Pennacchio F; Wisniak A; Dumont R; Baysson H; Richard V; Lorthe E; Semaani C; Balavoine JF; Pittet D; Vuilleumier N; Chappuis F; Kherad O; Azman AS; Posfay-Barbe K; Kaiser L; Guessous I; Euro Surveill; 2021 Oct; 26(43):. PubMed ID: 34713799 [TBL] [Abstract][Full Text] [Related]
24. Severe acute respiratory syndrome-coronavirus-2 seroprevalence study in Pimpri-Chinchwad, Maharashtra, India coinciding with falling trend - Do the results suggest imminent herd immunity? Banerjee A; Gaikwad B; Desale A; Jadhav SL; Rathod H; Srivastava K Indian J Public Health; 2021; 65(3):256-260. PubMed ID: 34558487 [TBL] [Abstract][Full Text] [Related]
25. Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003. Tseng WP; Wu JL; Wu CC; Kuo KT; Lin CH; Chung MY; Lee YF; Yang BJ; Huang CH; Chen SY; Yu CJ; Chen SC; Hsueh PR Front Immunol; 2021; 12():626609. PubMed ID: 34084161 [TBL] [Abstract][Full Text] [Related]
26. Seroprevalence and characteristics of Coronavirus Disease (COVID-19) in workers with non-specific disease symptoms. Javed W; Abidi SHB; Baqar JB BMC Infect Dis; 2022 May; 22(1):481. PubMed ID: 35596145 [TBL] [Abstract][Full Text] [Related]
27. Seroprevalence of COVID-19 infection among vaccine naïve population after the second surge (June 2020) in a rural district of South India: A community-based cross-sectional study. George CE; Inbaraj LR; Rajukutty S; Joan RF; Suseeladevi AK; Muthuraj S; Chandrasingh S PLoS One; 2022; 17(3):e0265236. PubMed ID: 35271669 [TBL] [Abstract][Full Text] [Related]
33. Seroprevalence of SARS-CoV-2 in the West Bank region of Palestine: a cross-sectional seroepidemiological study. Qutob N; Awartani F; Salah Z; Asia M; Abu Khader I; Herzallah K; Balqis N; Sallam H BMJ Open; 2021 Feb; 11(2):e044552. PubMed ID: 33542045 [TBL] [Abstract][Full Text] [Related]
34. SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May-June, 2021. Konu YR; Condé S; Gbeasor-Komlanvi F; Sadio AJ; Tchankoni MK; Anani J; Bitty-Anderson A; Mirindi BR; Diallo FBT; MIjiyawa M; Dagnra AC; Ekouevi DK BMC Public Health; 2022 Dec; 22(1):2294. PubMed ID: 36476149 [TBL] [Abstract][Full Text] [Related]
35. Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021. Raqib R; Sarker P; Akhtar E; Nurul Huda TM; Haq MA; Roy AK; Hosen MB; Haque F; Chowdhury MR; Reidpath DD; Emdadul Hoque DM; Islam Z; Ahmed S; Ahmed T; Tofail F; Razzaque A PLoS One; 2022; 17(5):e0268093. PubMed ID: 35604947 [TBL] [Abstract][Full Text] [Related]
36. [Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic]. Popova AY; Smirnov VS; Ezhlova EB; Mel'nikova AA; Samoilova LV; Lyalina LV; Semenova EV; Gurskiy MA; Aksenova EA; Arbuzova TV; Totolian AA Vopr Virusol; 2021 Sep; 66(4):299-309. PubMed ID: 34545722 [TBL] [Abstract][Full Text] [Related]
38. Seroprevalence of anti-SARS-CoV-2 IgG Antibodies in the Staff of a Public School System in the Midwestern United States. Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M medRxiv; 2020 Oct; ():. PubMed ID: 33140066 [TBL] [Abstract][Full Text] [Related]
39. Seroprevalence of SARS-CoV-2 in Pakistan: an update on epidemiological trends. Waqar M; Wahid B; Idrees M; Ali M; Rehman Z Z Naturforsch C J Biosci; 2021 Sep; 76(9-10):425-429. PubMed ID: 34161693 [TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area. Alroqi F; Masuadi E; Alabdan L; Nogoud M; Aljedaie M; Abu-Jaffal AS; Barhoumi T; Almasoud A; Alharbi NK; Alsaedi A; Khan M; Arabi YM; Nasr A J Infect Public Health; 2021 Sep; 14(9):1268-1273. PubMed ID: 34479078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]